History

We, 2023~2024: Discovery Part: DEL (DNA Encoded Library), Proteomics built in house
We, 2025: Build 5 clinical pipelines

Our challenge continues to make an innovative history of new drug development.
Pin Therapeutics
2022
02 Series B Closing
2021
05 Elected for Data Voucher Business (Korea Data Agency)
07 Elected for R&D Investment Infrastructure linked Government Project (Korea Health Industry Development Institute, KHIDI)
10 Tech Credit Bureau (TCB): TI- Third grade
04 Established Proteolytic Drug Research Center (Gwanggyo, Gyeonggi-do)
Established Proteolytic Drug Research Center (Gwanggyo, Gyeonggi-do)
03 Bridge funding (Undisclosed)
2020
05 Received the Grand Prize in PROTAC New Drug (2020 Korea Industry Best Enterprise Award)
Received the Grand Prize in PROTAC New Drug (2020 Korea Industry Best Enterprise Award)
2019
11 Received Venture Business Certification (2019-2024)
08 Series A (Undisclosed)
07 Flip between Pin US & Pin Therapeutics
2018
08 Join in JLABS at South San Francisco
03 Pin Therapeutics Korea established (renamed as Pin Therapeutics)
Pin Therapeutics Korea established  (renamed as Pin Therapeutics)
2017
11 Pre-series A (Undisclosed)
02 Pin therapeutics founded (Bay area, USA)
2016